Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Fibromyalgia
NCT00233025Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of duloxetine in fibromyalgia (FM), sponsored by Eli Lilly and Company. Started Sep 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00233025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233025.